Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
Berlin, October 24, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved…
Construction begins for the Berlin Center for Gene and Cell Therapies
Berlin, September 16, 2025 – A groundbreaking ceremony kicked off the construction work for the Berlin Center for…
New initiative launched to improve care for people with certain types of heart failure
The American Heart Association’s IMPLEMENT-EF program aims to reduce gaps in patient care, establish best practices for treating…